Marie Thibault
Stock Analyst at BTIG
(0.04)
# 4,561
Out of 4,581 analysts
733
Total ratings
36.9%
Success rate
-11.7%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Reiterated: Buy | $45 | $40.89 | +10.05% | 53 | Jul 24, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $85.76 | +28.26% | 44 | Jul 24, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $131 → $134 | $108.00 | +24.07% | 53 | Jul 16, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $185 | $122.44 | +51.09% | 61 | Jul 15, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $30 → $32 | $22.75 | +40.66% | 10 | Jul 15, 2026 | |
| DCTH Delcath Systems | Maintained: Buy | $16 → $17 | $11.58 | +46.80% | 31 | Jul 13, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $65 | $46.04 | +41.18% | 78 | Jul 10, 2026 | |
| DXCM DexCom | Maintained: Buy | $80 | $75.14 | +6.47% | 55 | Jul 10, 2026 | |
| XAIR Beyond Air | Maintained: Hold | n/a | $5.51 | - | 16 | Jul 10, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2 | $0.891 | +124.47% | 4 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.87 | - | 39 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $18.40 | +35.87% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2309 | - | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $85.42 | -1.66% | 13 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 | $170.62 | +37.73% | 50 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.68 | - | 28 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $28 | $17.73 | +57.92% | 11 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.80 | - | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.66 | +221.89% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $91.93 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $338.19 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $320.13 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $87.54 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.82 | n/a | 23 | Dec 16, 2022 |
AtriCure
Jul 24, 2026
Reiterated: Buy
Price Target: $45
Current: $40.89
Upside: +10.05%
Edwards Lifesciences
Jul 24, 2026
Reiterated: Buy
Price Target: $110
Current: $85.76
Upside: +28.26%
Abbott Laboratories
Jul 16, 2026
Maintained: Buy
Price Target: $131 → $134
Current: $108.00
Upside: +24.07%
iRhythm Holdings
Jul 15, 2026
Reiterated: Buy
Price Target: $185
Current: $122.44
Upside: +51.09%
Kestra Medical Technologies
Jul 15, 2026
Reiterated: Buy
Price Target: $30 → $32
Current: $22.75
Upside: +40.66%
Delcath Systems
Jul 13, 2026
Maintained: Buy
Price Target: $16 → $17
Current: $11.58
Upside: +46.80%
Boston Scientific
Jul 10, 2026
Maintained: Buy
Price Target: $65
Current: $46.04
Upside: +41.18%
DexCom
Jul 10, 2026
Maintained: Buy
Price Target: $80
Current: $75.14
Upside: +6.47%
Beyond Air
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $5.51
Upside: -
Hyperfine
Jul 10, 2026
Reiterated: Buy
Price Target: $2
Current: $0.891
Upside: +124.47%
Jul 9, 2026
Maintained: Hold
Price Target: n/a
Current: $4.87
Upside: -
Jul 9, 2026
Maintained: Buy
Price Target: $25
Current: $18.40
Upside: +35.87%
Jul 7, 2026
Rated: Hold
Price Target: n/a
Current: $0.2309
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $84
Current: $85.42
Upside: -1.66%
Jun 15, 2026
Maintained: Buy
Price Target: $235
Current: $170.62
Upside: +37.73%
Jun 15, 2026
Maintained: Hold
Price Target: n/a
Current: $3.68
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $30 → $28
Current: $17.73
Upside: +57.92%
Feb 18, 2026
Maintained: Hold
Price Target: n/a
Current: $3.80
Upside: -
Feb 18, 2026
Maintained: Buy
Price Target: $15
Current: $4.66
Upside: +221.89%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $91.93
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $338.19
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $320.13
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $87.54
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $1.82
Upside: n/a